N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase

A compound of the formula (I)

• in which
• R1A and R1B independently of one another represent hydrogen, methyl, ethyl or n-propyl
• or
• are attached to one another and together with the carbon atom to which they are attached form a cyclopropyl or cyclobutyl ring,
• R2A represents hydrogen, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, methoxy, ethoxy or cyclopropyloxy,
• R2B represents hydrogen or methyl,
• or
• R2A and R2B are attached to one another and together with the carbon atom to which they are attached form a cyclopropyl or cyclobutyl ring,
• R3 represents hydrogen, fluorine, chlorine, methyl, trifluoromethyl or ethyl,
• R4A and R4B independently of one another represent methyl, trifluoromethyl or ethyl
• or
• are attached to one another and together with the carbon atom to which they are attached form a cyclopropyl, cyclobutyl or cyclopentyl ring which may be substituted up to two times by fluorine
• and
• A represents an optionally substituted or fused piperidine ring of the formula
• wherein
• * denotes the point of attachment to the remainder of the molecule,
• R5 represents hydrogen, (C1-C4)-alkyl, cyclopropyl, cyclobutyl, methoxy, ethoxy or phenyl, where (C1-C4)-alkyl for its part may be substituted up to three times by fluorine,
• R5B represents hydrogen or methyl,
• or
• R5A and R5B are attached to one another and together with the carbon atom to which they are attached form a cyclopropyl or cyclobutyl ring,
• and
• R6 represents hydrogen, fluorine, chlorine, methyl or trifluoromethyl,
• or a salt, solvate, or a solvate of the salt thereof.